BLAINJECTIONINJECTABLE
Approved
Aug 1975
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PERGONAL is a menotropin injection containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH), used to stimulate ovarian follicle development in fertility treatment. It is a human menopausal gonadotropin derived from urinary sources, indicated for ovulation induction and assisted reproductive technology (ART) cycles. The drug works by directly replacing endogenous gonadotropins to promote follicular growth and maturation.
LOE Approaching
With LOE approaching and modest competitive pressure (30%), the PERGONAL team is likely in maintenance and transition mode, suggesting smaller commercial teams focused on retention rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
Merck & Co. is hiring 1 role related to this product
Worked on PERGONAL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.